Laekna, Inc. engages in the provision of clinical stage research and development of biopharmaceutical products. It primarily focuses on cancer and liver fibrosis. The company was founded by Xiang Yang Lu on July 29, 2016 and is headquartered in Shanghai, China.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
86
Frequently Asked Questions
What is the 52-week high for Laekna Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Laekna Inc. 52 week high is $7.30 as of October 19, 2025.
What is the 52-week low for Laekna Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Laekna Inc. 52 week low is $1.90 as of October 19, 2025.
What is Laekna Inc. stock price today?
Laekna Inc. stock price today is $2.21.
What was Laekna Inc. stock price yesterday?
Laekna Inc. stock price yesterday was $2.10.
What is the PE ratio of Laekna Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Laekna Inc.’s P/E ratio is -24.45.
What is the Price-to-Book ratio of Laekna Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Laekna Inc. P/B ratio is 8.4600.
What is the 50-day moving average of Laekna Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Laekna Inc. 50-day moving average is $2.18.
